Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDArcutis Biotherapeutics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$0.26 | $0.16 | -$0.06 |
| Q2 2026 | 4 | $0.02 | $0.08 | $0.06 |
| Q3 2026 | 4 | $0.15 | $0.21 | $0.18 |
| Q4 2026 | 4 | $0.03 | $0.44 | $0.25 |
| Q1 2027 | 1 | $0.14 | $0.14 | $0.14 |
| Q2 2027 | 1 | $0.22 | $0.23 | $0.22 |
| Q3 2027 | 1 | $0.27 | $0.29 | $0.28 |
| Q4 2027 | 1 | $0.43 | $0.45 | $0.44 |
Arcutis Biotherapeutics Inc Earnings Date And Information
Arcutis Biotherapeutics Inc last posted its earnings results on Wednesday, August 5th, 2026. The company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $0.05508 by $0.05492. The company had revenue of 129.86 M for the quarter and had revenue of 376.07 M for the year. Arcutis Biotherapeutics Inc has generated $0 earnings per share over the last year ($-0.13 diluted earnings per share) and currently has a price-to-earnings ratio of 113.59. Arcutis Biotherapeutics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Arcutis Biotherapeutics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2026 | Q2 2026 | $0.06 | $0.11 | 0.05 | $118.85 M | $129.86 M |
| 05/06/2026 | Q1 2026 | -$0.02 | -$0.09 | -0.07 | $103.68 M | $105.40 M |
| 02/25/2026 | Q4 2025 | $0.03 | $0.14 | 0.11 | $113.06 M | $129.50 M |
| 10/28/2025 | Q3 2025 | -$0.10 | $0.06 | 0.16 | $86.97 M | $99.22 M |
| 08/06/2025 | Q2 2025 | -$0.18 | -$0.13 | 0.05 | $73.69 M | $81.50 M |
| 05/06/2025 | Q1 2025 | -$0.21 | -$0.20 | 0.01 | $62.23 M | $65.85 M |
| 02/25/2025 | Q4 2024 | -$0.28 | -$0.09 | 0.19 | $60.79 M | $71.36 M |
| 11/06/2024 | Q3 2024 | -$0.42 | -$0.33 | 0.09 | $37.62 M | $44.76 M |
| 08/14/2024 | Q2 2024 | -$0.48 | -$0.42 | 0.06 | $29.09 M | $30.86 M |
| 05/14/2024 | Q1 2024 | -$0.60 | -$0.32 | 0.28 | $15.18 M | $49.57 M |
| 02/27/2024 | Q4 2023 | -$0.65 | -$0.72 | -0.07 | $11.41 M | $13.53 M |
| 11/03/2023 | Q3 2023 | -$0.90 | -$0.73 | 0.17 | $32.91 M | $38.11 M |
| 08/08/2023 | Q2 2023 | -$1.22 | -$1.16 | 0.06 | $4.60 M | $5.19 M |
| 05/09/2023 | Q1 2023 | -$1.30 | -$1.30 | 0 | $3.14 M | $2.78 M |
| 02/28/2023 | Q4 2022 | -$1.37 | -$1.24 | 0.13 | $2.20 M | $2.96 M |
| 11/08/2022 | Q3 2022 | -$1.54 | -$1.94 | -0.4 | $614.29 K | $725.00 K |
| 08/04/2022 | Q2 2022 | -$1.38 | -$1.34 | 0.04 | N/A | $0 |
| 05/05/2022 | Q1 2022 | -$1.42 | -$1.31 | 0.11 | N/A | $0 |
| 02/22/2022 | Q4 2021 | -$1.41 | -$1.42 | -0.01 | N/A | $0 |
| 11/04/2021 | Q3 2021 | -$1.09 | -$1.14 | -0.05 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Arcutis Biotherapeutics Inc Earnings: FAQ's
In the previous quarter, Arcutis Biotherapeutics Inc (:ARQT) reported $0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $0.05508 by $0.05492.
The conference call for Arcutis Biotherapeutics Inc's latest earnings report can be listened to online.
The conference call transcript for Arcutis Biotherapeutics Inc's latest earnings report can be read online.
Arcutis Biotherapeutics Inc (:ARQT) has a recorded annual revenue of $376.07 M.
Arcutis Biotherapeutics Inc (:ARQT) has a recorded net income of $-16,140,999.Arcutis Biotherapeutics Inc has generated $-0.13 earnings per share over the last four quarters.
Arcutis Biotherapeutics Inc (:ARQT) has a price-to-earnings ratio of 113.59 and price/earnings-to-growth ratio is 0.02.